Journal article

Continuing or ceasing bevacizumab beyond progression in recurrent glioblastoma: an exploratory randomized phase II trial

Elizabeth J Hovey, Kathryn M Field, Mark A Rosenthal, Elizabeth H Barnes, Lawrence Cher, Anna K Nowak, Helen Wheeler, Kate Sawkins, Ann Livingstone, Pramit Phal, Christine Goh, John Simes

Neuro-Oncology Practice | OXFORD UNIV PRESS | Published : 2017


Awarded by NHMRC Program

Funding Acknowledgements

This study was funded by Roche Products, Pty Limited (Australia) with additional support from NHMRC Program Grant 1037786 to the NHMRC Clinical Trials Centre, and Cancer Australia Support for Cancer Clinical Trials Grant and CINSW Cooperative Clinical Trials Grant to COGNO.Dr. Field was funded through the University of Melbourne Stella Mary Langford Scholarship, Watt-Geyer Memorial Research Fund, and the Royal Melbourne Hospital Research Medal